跳到主要內容

MBX Biosciences, Inc.

MBX
交易所
Nasdaq
產業
Pharmaceutical Preparations
SEC CIK
0001776111

近 90 天,MBX Biosciences, Inc. 內部人申報 0 筆公開市場買進、1 筆賣出;2026 年第 2 季末有 172 家機構在 13F 申報持有,市值合計 $30.6 億;沒有大師持有。

2024 年第 3 季與 2024 年第 2 季比較

持有 MBX Biosciences, Inc. 的機構從 2024 年第 2 季到 2024 年第 3 季的變化。

2024 年第 3 季全部持有人2024 年第 2 季全部持有人

MBX 的 13F 持有人:2024 年第 2 季與 2024 年第 3 季比較
項目2024 年第 2 季2024 年第 3 季變化
持有家數045+45
股數03,031 萬+3,031 萬
市值$0$7.84 億+$7.84 億

新進機構(45 家)

2024 年第 3 季季末持有 MBX Biosciences, Inc.、2024 年第 2 季季末沒有持有的機構。

2024 年第 3 季新進 MBX 的機構
機構股數市值佔組合 %
Frazier Life Sciences Management, L.P.5,985,347$1.55 億6.23%
OrbiMed Advisors LLC3,812,215$9,904 萬1.81%
NEA Management Company, LLC3,614,486$9,390 萬5.12%
Deep Track Capital, LP3,018,935$7,843 萬2.50%
Wellington Management Group LLP2,937,853$7,426 萬0.01%
NVP Associates, LLC2,136,335$5,550 萬31.51%
Ra Capital Management, L.P.1,511,334$3,926 萬0.45%
Price T Rowe Associates Inc1,192,938$3,099 萬0.00%
EcoR1 Capital, LLC1,175,809$3,055 萬1.05%
Driehaus Capital Management LLC981,322$2,549 萬0.22%
Cormorant Asset Management, LP700,000$1,819 萬0.96%
TCG Crossover Management, LLC650,000$1,689 萬1.43%
Woodline Partners LP519,675$1,350 萬0.11%
Millennium Management LLC440,411$1,144 萬0.01%
Franklin Resources Inc450,000$1,060 萬0.00%
Alyeska Investment Group, L.P.225,000$584.5 萬0.03%
Platinum Investment Management Ltd150,000$389.7 萬0.18%
Citadel Advisors LLC135,608$352.3 萬0.00%
Goldman Sachs Group Inc51,000$132.5 萬0.00%
Vanguard Group Inc50,000$129.9 萬0.00%
Monashee Investment Management LLC50,000$129.9 萬0.14%
Maven Securities LTD50,000$129.9 萬0.15%
StemPoint Capital LP50,000$129.9 萬0.39%
Manufacturers Life Insurance Company, The46,194$120.0 萬0.00%
TD Asset Management Inc44,782$107.3 萬0.00%
Soros Fund Management LLC大師索羅斯基金管理30,000$77.9 萬0.02%
Ghisallo Capital Management LLC30,000$77.9 萬0.04%
Teachers Retirement System of the State of Kentucky26,708$69.4 萬0.01%
Jane Street Group, LLC26,570$69.0 萬0.00%
Norges Bank25,000$65.0 萬0.00%
Point72 (DIFC) Ltd24,011$62.4 萬0.05%
Geode Capital Management, LLC22,269$57.9 萬0.00%
HRT Financial LP21,637$56.2 萬0.00%
Squarepoint Ops LLC16,470$42.8 萬0.00%
Barclays PLC16,400$42.6 萬0.00%
Point72 Asset Management, L.P.15,600$40.5 萬0.00%
Shay Capital LLC15,000$39.0 萬0.11%
Davidson Kempner Capital Management LP13,500$33.8 萬0.01%
Marshall Wace, LLP12,000$31.2 萬0.00%
Point72 Asia (Singapore) Pte. Ltd.10,706$27.8 萬0.05%
Capula Management Ltd8,362$21.7 萬0.00%
Sandia Investment Management LP5,000$13.0 萬0.21%
Legal & General Group Plc5,000$12.8 萬0.00%
Aster Capital Management (DIFC) Ltd1,810$4.70 萬0.01%
Tower Research Capital LLC (TRC)154$4,0010.00%

清倉機構(0 家)

2024 年第 2 季季末持有 MBX Biosciences, Inc.、2024 年第 3 季有申報但已經沒有持有的機構。

沒有。